Research Article
Evaluation of Hepatoprotective Potential of Polyherbal Preparations in CCl4-Induced Hepatotoxicity in Mice
Table 3
Dosage of orally administered drug in various groups in phenobarbitone-induced sleeping time.
| Groups | Treatment |
| Group 11 | Normal control; received distilled water for 7 days (p.o.) + phenobarbitone single dose on day 9. | Group 12 | Pathological control; distilled water for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 13 | Received holyliv formulation at 2.6 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 14 | Received holyliv formulation at 5.2 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 15 | Received heptaliv formulation at 2.6 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 16 | Received heptaliv formulation at 5.2 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 17 | Received icturn formulation at 2.6 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 18 | Received icturn formulation at 5.2 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 19 | Received J-Deenar formulation at 2.6 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. | Group 20 | Received J-Deenar formulation at 5.2 ml/kg BW/d for 7 days (p.o.) + CCl4 single dose on day 8 + phenobarbitone single dose on day 9. |
|
|